Considering Fas ligand as a target for therapy

Author： Linkermann Andreas Qian Jing Lettau Marcus Kabelitz Dieter Janssen Ottmar

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.1, 2005-02, pp. : 119-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fas Ligand Gene Therapy for Vascular Intimal Hyperplasia

Current Gene Therapy, Vol. 4, Iss. 1, 2004-01 ,pp. : 33-39

Bentham Science Publishers

Access to resources Recommend Favorite

Fas ligand: a potential target for therapeutic immune modulation in transplantation and inflammatory diseases

By O'Connell J.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 503-512

Informa Healthcare

Access to resources Recommend Favorite

Fas ligand: a potential target for therapeutic induction of apoptosis and enhancing immunotherapy in cancer

By O'Connell J.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 601-611

Informa Healthcare

Access to resources Recommend Favorite

The Use of Fas Ligand, TRAIL and Bax in Gene Therapy of Prostate Cancer

Current Gene Therapy, Vol. 1, Iss. 1, 2001-05 ,pp. : 123-136

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Fas/Fas ligand pathway in cancer

By O’Brien Darren I Nally Ken Kelly Raymond G O’Connor Terrence M Shanahan Fergus O’Connell Joe

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1031-1044

Informa Healthcare

Access to resources Recommend Favorite